Durham startup’s $100M fundraiser could help lead to revolution in gene therapies
Kriya Therapeutics is poised to revolutionize gene therapies for highly serious diseases like diabetes and severe obesity after landing a whopping $100 million in capital.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
